Neumora Therapeutics, Inc. (NMRA) vs Tenaya Therapeutics, Inc. (TNYA)

Neumora Therapeutics, Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Neumora Therapeutics, Inc. and Tenaya Therapeutics, Inc. are of similar size ($139.0M and $135.3M). Across the 9 metrics below, Tenaya Therapeutics, Inc. leads on 8 and Neumora Therapeutics, Inc. on 1.

Valuation

Metric NMRA TNYA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.83 1.91 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (180.88%) (86.89%) (28.84%)
Free cash flow yield (143.21%) (39.62%) (23.03%)

Profitability

Metric NMRA TNYA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (187.11%) (121.86%) (57.72%)
Return on assets (121.89%) (95.61%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NMRA TNYA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 5.23% 54.96% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NMRA TNYA Biotechnology median
Debt to equity 1.19 0.00 0.00
Current ratio 4.50 4.52 4.73
Net debt to EBITDA 0.53 1.19 0.96

Dividend

Metric NMRA TNYA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric NMRA TNYA Biotechnology median
Market cap 135.29m 139.02m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack